NCT04618237 Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient Status UNKNOWN Phase N/A
NCT04583618 Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years. Status COMPLETED Phase PHASE2
NCT04572841 Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) Status COMPLETED Phase PHASE2
NCT04558931 Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma Status RECRUITING Phase PHASE2
NCT04550962 Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT) Status COMPLETED Phase N/A
NCT04524689 Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC Status TERMINATED Phase PHASE2
NCT04521738 First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects Status COMPLETED Phase PHASE1
NCT04502862 A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma Status COMPLETED Phase PHASE4
NCT04492254 Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients Status TERMINATED Phase PHASE3
NCT04483739 Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04478266 Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer Status TERMINATED Phase PHASE3
NCT04469621 A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 Status COMPLETED Phase PHASE1
NCT04458831 A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) Status COMPLETED Phase N/A
NCT04458051 Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) Status COMPLETED Phase PHASE3
NCT04456673 Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation Status COMPLETED Phase PHASE3
NCT04442269 Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) Status COMPLETED Phase PHASE2